Organon & Co. Files 8-K on Financials

Ticker: OGN · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1821825

Organon & CO. 8-K Filing Summary
FieldDetail
CompanyOrganon & CO. (OGN)
Form Type8-K
Filed DateAug 5, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

TL;DR

Organon filed an 8-K on Aug 5th covering financials and operations.

AI Summary

Organon & Co. filed an 8-K report on August 5, 2025, detailing results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and headquartered in Jersey City, NJ.

Why It Matters

This filing provides investors with crucial updates on Organon & Co.'s financial performance and operational status, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any unusual or significant risks.

Key Numbers

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K?

The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported was on August 5, 2025.

Where is Organon & Co. headquartered?

Organon & Co.'s principal executive offices are located at 30 Hudson Street, Floor 33, Jersey City, NJ 07302.

What is Organon & Co.'s Commission File Number?

Organon & Co.'s Commission File Number is 001-40235.

What is the SIC code for Organon & Co.?

The Standard Industrial Classification code for Organon & Co. is 2834, Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding Organon & Co. (OGN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing